INSIGHT: A Phase III Trial of Ripretinib Versus Sunitinib in Patients with Advanced GIST with KIT Exon 11 and Exon 17/18 Mutations Who Were Previously Treated with Imatinib.

ABSTRACT:

SUBMITTER: Larrain C 

PROVIDER: S-EPMC11976832 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature